Latest California Healthline Stories
In Arizona, Health Law’s Gains And Losses Play In Presidential Race
Clinton has offered detailed plans to preserve and expand the law, while Trump has vowed to “repeal and replace Obamacare so quickly.”
Veterans Courted In California’s Ballot Fight Over Curbing Drug Prices
The initiative would prohibit California state agencies from paying more for a prescription drug than what the Department of Veterans Affairs pays. Both sides are deploying veterans’ sympathetic and trusted image to win over voters.
Candidates Decry High Drug Prices But Have Few Options For Voters
Drug prices rise for a variety of reasons but opportunities for the government to control them is limited.
Should Proposition 64 Pass Or Go Up In Smoke?
Two voices from law enforcement disagree on ballot measure to legalize marijuana.
A Look At Veep Pick Tim Kaine’s Record On Health Care
As a Democratic senator and governor, Tim Kaine has backed the Affordable Care Act, Medicaid expansion and better access to mental health treatment for people in crisis.
Hospital Finance Measure On State Ballot May Stump Voters
Proposition 52 would permanently enshrine a significant source of funding for hospitals and limit lawmakers’ ability to change it.
Sounds Like A Good Idea? Regulating Drug Prices
Presidential candidates from both parties have proposals they say would help lower the cost of prescription drugs. But most experts say that efforts to regulate prices might not end up saving much money.
Hospital Workers Union Pulls California Ballot Measure On Hospital Exec Pay
The proposed initiative, which had enough signature to qualify for the November ballot, would have limited the annual pay of hospital executives to $450,000.
As Marijuana Legalization Initiative Heads For California Ballot, Health Groups Weigh In
Health experts remain divided on legalizing marijuana for recreational use.
Report From Key Agency Raises Concerns About Proposal To Cut Drug Prices
Staff researchers at California’s largest public buyer of health benefits say the goal of reducing drug costs for the state is appealing but might not work in the real world.